Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Chlordiazepoxide hydrochloride  (1)
  • Olanzapine  (1)
  • R04-4602  (1)
  • 1
    Digitale Medien
    Digitale Medien
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 355 (1997), S. 361-364 
    ISSN: 1432-1912
    Schlagwort(e): Key words Clozapine ; Olanzapine ; Loxapine ; SCH 23390 ; Catalepsy
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract Loxapine (0.3mg/kg s.c.), olanzapine (10 mg/ kg s.c.) and SCH 23390 (R-(+)-chloro-2, 3, 4, 5-tetrahydro-3-methyl-5-phenyl-1-H-3-benzazepine; 1mg/kg, s.c.), but not clozapine (10mg/kg, s.c.), induced catalepsy in rats. Co-administration of clozapine (1, 3 and 10mg/ kg s.c.) dose-dependently inhibited loxapine-induced catalepsy. Clozapine (10mg/kg s.c.) also prevented the induction of catalepsy by olanzapine. In addition, clozapine abolished the catalepsy induced by loxapine when it was administered after the response had fully developed. In contrast, the duration of SCH 23390-induced catalepsy was prolonged by clozapine, indicating that its anti-catalepsy effects against olanzapine and loxapine are unlikely to be caused by muscle relaxation, sedation or stimulation. Since SCH 23390-induced catalepsy is reported to be blocked by scopolamine, dizocilpine (MK-801) or 8-hydroxy-dipropylamino-tetralin, it is unlikely that muscarinic blockade, NMDA ion channel blockade and 5-HT1A receptor agonism, respectively, are involved in clozapine’s action, but the mechanism by which clozapine exerts this anti-cataleptic effect remains unknown.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1432-2072
    Schlagwort(e): R04-4602 ; 5-HT Antagonists ; Activity ; Tryptophan
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract l-Tryptophan at moderately low dosage (20 mg/kg) reduced the activity of rats taken during a dark period (red light) and put into an open field illuminated by bright white light. Activity was not altered when the field was illuminated by red light. Tryptophan did not cause significant hypoactivity in rats pretreated with the 5-hydroxytryptamine (5-HT) receptor antagonists methysergide, cyproheptadine and metergoline. However, tryptophan did not alter brain 5-HT concentration and only increased 5-hydroxyindoleacetic acid (5-HIAA) slightly in rats killed shortly after behavioural observation. A further indication that the behavioural effect of tryptophan was not due to increased brain 5-HT was its prevention by R04-4602 at a dose sufficient to block peripheral but not central l-aromatic amino acid decarboxylase. The results suggest that the above behavioural effect of l-tryptophan is peripherally mediated. A number of potential mechanism are discussed.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    ISSN: 1432-2072
    Schlagwort(e): Elevated plus maze ; Anxiety ; Chlordiazepoxide hydrochloride ; d-Amphetamine sulphate ; FG 7142 ; Buspirone ; Locomotor activity ; Rats
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract In exploratory animal models of anxiety, such as the elevated plus maze, the anxiogenic- and anxiolytic-like effects of drugs may be confounded by changes in locomotor activity. In the present experiments, the sensitivity of several measures of anxiety and locomotor activity in the elevated plus maze were assessed. Both chlordiazepoxide hydrochloride (CDP, 7.5 mg/kg) andd-amphetamine sulphate (AMP, 0.75, 1.5 mg/kg) increased the percent time on the open arms and doses of 7.5 mg/kg and 1.5 mg/kg CDP and AMP, respectively, increased the number of entries into the open arms. The increase in these measures might suggest that both compounds induced an anxiolytic-like effect. Although FG 7142 (30.0 mg/kg) did not decrease the number of entries to the open arms, it did decrease the time on the open arms, which might suggest that it had anxiogenic-like effects. Similarly, buspirone reduced both the number of entries into the open arms and the time spent on the open arms. However, all the compounds significantly affected locomotor activity. CDP (3.0 and 7.5 mg/kg) increased the total number of arm entries, the distance travelled on the open arms and the mean speed of the animals on the open, and in the closed arms. Moreover, the distance travelled by the animals in the closed arms was increased by 1.0 mg/kg CDP, a dose that had no measurable effects on the indices of anxiety. Similarly, although AMP failed to increase the total number of arm entries, it did increase the distance travelled in the closed arms (0.75 and 1.5 mg/kg), on the open arms (1.5 mg/kg) and the speed of the animals in the closed arms (1.5 mg/kg), a measure that is independent of the time spent in the closed arms. By contrast, both FG 7142 (30.0 mg/kg) and buspirone decreased the total number of arm entries (0.3–8.0 mg/kg), the speed of the animals in the closed arms and the distance travelled in the closed arms (1.0–4.0 mg/kg). These experiments suggest that: (i) the anxiogenic- and anxiolytic-like effects of drugs in the elevated plus-maze are confounded by changes in locomotor activity and that “total arm entries” is a relatively insensitive measure of drug-induced changes in locmotor activity; (ii) psychostimulant compounds, such as AMP, at doses that increase locomotor activity have an anxiolytic-like profile in the elevated plus maze and (iii) the measurement of speed of movement is a more sensitive index of changes in locmotor activity than the conventional measure of “total arm entries”.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...